Both in Pharmaceuticals
ADC Therapeutics SA vs Keros Therapeutics
Over the past year ADCT returned −63.1% and KROS returned −29.3%; their daily moves had a correlation of 0.14.
ADCT −63.1% KROS −29.3%Growth of $1, one year, split-adjusted
| Metric | ADCT | KROS |
|---|---|---|
| Price | $1.70 | $11.23 |
| Market cap | $217.0M | $222.7M |
| Today | −8.60% | −3.27% |
| 1 month | +53.2% | +0.2% |
| 6 months | −56.0% | −2.8% |
| Year to date | −51.8% | −44.8% |
| 1 year | −61.5% | −28.5% |
| Revenue growth (YoY) | +2.2% | −100.0% |
| Gross margin | 87.8% | — |
| Net margin | −86.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.7× | 14.8× |
| Net cash | $102.5M | $257.6M |
| Dividend yield | — | — |
| Volatility (60d) | 89.6% | 45.2% |
| Short % of float | 7.0% | 6.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).